Trial Profile
Androgen Deprivation Therapy With or Without Radium-223 Dichloride in Patients With Newly Diagnosed Metastatic Prostate Cancer With Bone Metastases: Hoosier Cancer Research Network GU13-170
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Bicalutamide (Primary)
- Indications Adenocarcinoma; Bone metastases; Prostate cancer
- Focus Therapeutic Use
- 10 May 2019 Status changed from active, no longer recruiting to discontinued as the funding was withdrawn.
- 12 Jul 2018 Planned primary completion date changed from 1 Jun 2018 to 1 Sep 2018.
- 20 Feb 2018 Planned primary completion date changed from 1 Jan 2018 to 1 Jun 2018.